Stay updated on GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.

Latest updates to the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe error page’s footer revision label changed from v3.7.1 to v3.7.2; the study record still displays a 403 Forbidden message.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check20 days agoChange DetectedThe study record has been replaced by a 403 Forbidden message and a Home link, leaving the trial details unavailable.SummaryDifference0.5%

- Check34 days agoChange DetectedThe page now shows a 403 Forbidden error, and the detailed study content is replaced by an error screen with limited navigation.SummaryDifference20%

- Check48 days agoChange DetectedThere are no additions or deletions to report, so the page content remains unchanged. This indicates no updates to the study details were captured in the provided data.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing Revision: v3.6.5, indicating a minor site update.SummaryDifference0.1%

Stay in the know with updates to GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.